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Multifunctional nanoparticles (MFNPs) have shown great promise as new probes for
biomedical imaging and carriers for drug delivery.1 MFNPs can not only carry large payloads
of imaging and/or therapeutic agents, but also be rendered target-specific by conjugation to
affinity molecules which have avidity for cell surface markers. Although a number of strategies
have been developed to synthesize target-specific MFNPs, most of them rely on covalent
attachment of affinity molecules to their surfaces.2 Since such bioconjugation steps can be
tedious, there exists a need for new synthetic strategies toward imaging and/or therapeutic
MFNPs that can specifically target diseased cells. Herein we wish to report a noncovalent,
electrostatic layer-by-layer (LbL) self-assembly strategy for the synthesis of cancer-specific
MFNPs that are efficient contrast agents for multimodal imaging.
LbL self-assembly, which was first reported almost 25 years ago,3 utilizes a wide range of
interactions of varied strength, including covalent bonds,4 metal-ligand coordination,5 and
electrostatic attractions between oppositely charged polyelectrolytes.6 Whereas molecular
self-assembly was initially developed for depositing monolayer and multilayer films on planar
substrates, electrostatic LbL self-assembly of polyelectrolytes has recently been shown to be
a versatile strategy for the synthesis of core-shell nanostructures and nanoshells.7 In this work,
we have prepared cancer-specific MFNPs by LbL self-assembly of polyelectrolytes and
explored their in vitro applications in magnetic resonance (MR) and optical imaging.
Scheme 1 illustrates our LbL self-assembly strategy for MFNPs which were synthesized
starting from recently reported hybrid silica nanoparticles (NP0) containing a luminescent [Ru
(bpy)3]Cl2 core and a paramagnetic monolayer coating of the Gd-(siloxylpropyl)
diethylenetriamine tetraacetate (Gd-DTTA) complex.8 NP0 is a highly anionic nanoparticle
owing to the negative charge on the Gd-DTTA complex and, as a result, allows the deposition
of cationic Gd(III)-DOTA oligomer 1 via electrostatic interactions to afford NP1A. It has been
shown that nanoparticles terminated with positively charged polyelectrolytes carry net positive
charge to allow further deposition of anionic polymers via electrostatic interactions.7
Treatment of NP1A with polystyrenesulfonate (PSS) yielded NP1B with a bilayer of 1 and
PSS. Repetition of this LbL deposition sequence led to MFNPs with alternate multilayer
coatings of positively charged 1 and negatively charged PSS. These MFNPs are designated
NPnA or NPnB with n denoting the number of 1 or PSS coating and A and B denoting surface
termination with 1 and PSS, respectively.
TEM images indicated alternate deposition of 1 and PSS onto the nanoparticles (Figure 1a-c);
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As shown in Figure 1d, the average diameters of the nanoparticles linearly increased as more
bilayers of 1 and PSS were deposited. To further probe alternate deposition of 1 and PSS, we
have prepared a fluorescein isothiocyanate (FITC)-labeled cationic Gd-DOTA oligomer 1a.
Upon excitation at 488 nm, [Ru(bpy)3]Cl2-doped NP0 emitted at 615 nm whereas the FITC
dye emitted at 515 nm. Since the luminescence intensity at 615 nm is proportional to the
NP0 concentration, the ratio of the 515 nm emission intensity to 615 nm emission intensity is
proportional to the number of FITC molecules on each nanoparticle. As shown in Figure 1e,
the ratio between 515 nm emission and 615 nm emission increased quadratically as more layers
of 1a and PSS were deposited. This result is consistent with the linear increase of particle
diameter since the number of FITC molecules is proportional to the surface area of spherical
nanoparticles (which scales quadratically with the particle diameter).
We have determined longitudinal (r1) and transverse (r2) MR relaxivities for the LbL
nanoparticles (NPnA) with up to seven layers of 1. Interestingly, the relaxivity values for
NPnA on a per Gd basis remain essentially constant at r1=19.0±1.7 mM-1·s-1 and r2=55.0±5.0
mM-1·s-1 regardless the number of deposited layers of 1. This result is in stark contrast with
that of the nanoparticles with covalently-attached multilayers of Gd chelates which exhibited
diminished relaxivities on a per Gd basis.8 We believe that the highly disordered and
hydrophilic nature of 1 and PSS on NPnA allows ready accessibility of water molecules to the
Gd centers for efficient water proton relaxation. Based on the size of LbL particles, we further
estimated r1 and r2 relaxivities for NPnA on a per particle basis which increased linearly as
more layers of 1 were electrostatically deposited onto NP0 (Figure 2a). The per particle r1
values increase from 1.94×105 mM-1·s-1 for NP0 to 5.34×105 mM-1·s-1 for NP7A whereas the
per particle r2 values increase from 5.61×105 mM-1·s-1 for NP0 to 1.55×106 mM-1· s-1 for
NP7A. The LbL self-assembly thus offers a superb strategy for increasing nanoparticle MR
relaxivities.
Since LbL self-assembled nanoparticles (NPnB) are terminated with anionic PSS polymers,
we hypothesized that NPnB can be further non-covalently functionalized with targeting
peptides that carry positive charges under physiological conditions. A peptide sequence
containing arginine-glycine-aspartate (RGD) and seven consecutive lysine (K) residues
(K7RGD) was chosen for this study. The negatively charged PSS layer can electrostatically
interact with positively charged lysine residues of the K7RGD sequence to lead to surface
functionalization of NPnB particles with the RGD sequence. The RGD peptide is known to
bind strongly (with a Kd in the μM range) to the integrin cell surface receptors that are
upregulated in growing endothelial and angiogenic cancer cells.9 We used human colon cancer
(HT-29) cells and calf pulmonary artery endothelial (CPAE) cells for in vitro labeling studies.
HT-29 cells are known to overexpress integrin receptors 10 and have been previously labeled
with K7RGD-functionalized protein microspheres.11
T1-weighted MR images of HT-29 cells after incubation with various nanoparticles are shown
in Figure 2b. Significant signal enhancement in the T1-weighted image was observed only for
HT-29 cells incubated with NP3B particles that have been non-covalently functionalized with
the K7RGD sequence. In contrast, no signal enhancement was observed for the HT-29 cells
incubated with either NP5B particles or NP5B particles non-covalently functionalized with
the K7GRD sequence. The K7GRD peptide was used here as a scramble to mimic the surface
charge of the nanoparticles but without providing affinity for the integrin receptors. In vitro
MR imaging studies demonstrated efficient targeting of cancer cells by the LbL particles with
non-covalently attached K7RGD peptide.
We have confirmed the targeting capability of LbL nanoparticles using laser scanning confocal
fluorescence microscopic (LSCFM) imaging. As shown in Figures 2c-2j, significant
luminescent signal was observed for HT-29 cells incubated with NPnB particles that have been
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non-covalently functionalized with the K7RGD sequence, indicating efficient targeting of
HT-29 cells by the electrostatically attached K7RGD peptide. In comparison, no or little
luminescent signal was observed for control HT-29 cells without nanoparticles and for the cells
that had been incubated with NP5B particles or NP5B particles non-covalently functionalized
with the scrambled K7GRD sequence. This result has been further supported by LSCFM studies
of CPAE cells which also showed cell targeting by the NPnB particles with non-covalently
attached K7RGD peptide (supporting info).
In summary, we have utilized electrostatic LbL self-assembly to construct MFNPs with both
MR and optical imaging capabilities. The LbL self-assembly strategy not only affords MFNPs
with extraordinarily high MR relaxivities but also provides an efficient means for non-covalent
functionalization of MFNPs with affinity molecules. The generality of this approach should
allow the design of imaging and/or therapeutic MFNPs that can specifically target a wide range
of diseased cells.
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(a-c) TEM images of nanoparticles that have been terminated with cationic Gd-DOTA
oligomer 1: (a) NP1A; (b) NP3A; (c) NP6A. (d) Dependence of NPnA particle size on the
number of deposited 1. (e) Dependence of the intensity ratio between FITC (515 nm) and [Ru
(bpy)3]Cl2 (615 nm) luminescence on the number of deposited FITC-labeled Gd-DOTA
oligomer 1a.
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(a) Dependence of per particle r1 and r2 values on the number of deposited Gd-DOTA oligomer
1 on NP0. (b) T1-weighted MR images of HT-29 cells that have been incubated with various
nanoparticles. From left to right: control cells without any nanoparticle, cells with NP3B
particles, cells with NP3B particles that have been non-covalently functionalized with K7RGD,
and cells with NP3B particles that have been non-covalently functionalized with K7GRD. (c-
j) Phase contrast optical (c, e, g, and i) and LSCFM microscopic images (d, f, h, and j) of HT-29
cells that have been incubated with various nanoparticles: control cells without any
nanoparticle (c and d), cells with NP5B particles (e and f), cells with NP5B particles that have
been non-covalently functionalized with K7RGD (g and h), and cells with NP5B particles that
have been non-covalently functionalized with K7GRD (i and j).
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